Women's imaging vendor Hologic has signed a definitive agreement to sell its Lifecodes business unit to Immucor.
Under the terms of the agreement, Hologic will receive $85 million in cash at the close of the transaction and may earn a contingent payment of $10 million based on certain financial targets for 2013. The transaction is expected to close during the second fiscal quarter.
Hologic acquired Lifecodes as part of its 2012 acquisition of Gen-Probe. Lifecodes sells molecular and antibody-based assays in the transplant diagnostics, specialty coagulation, and transfusion medicine markets.
